Skip to content

Clinical trials

Phase 2 Staphylococcal Infections trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Staphylococcal Infections Phase: Phase 2 Country / region: United States Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20081
20092
20111
20142
20151
20163
20171
20181
20191
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)4
M.D. Anderson Cancer Center2
Arsanis, Inc.1
Bristol-Myers Squibb1
Cellceutix Corporation1
ContraFect1
Crouse Hospital1
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Destiny Pharma Plc1
NovaDigm Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Staphylococcal Infections18
Bacteremia4
Abscess2
Cellulitis2
Sepsis2
Surgical Wound Infection2
Bacterial Infections1
Catheter-Related Infections1
Critical Illness1
Cross Infection1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.